Merck & Co., Inc. LVTX Holdings History
Number of Shares
1.15 Mil
Current Holdings Value*
$1.46 Mil
% of Portfolio
0.89%
Total Estimate Gain
$-241,362.45
% of Total Estimate Gain
-13.38%
Merck & Co., Inc.'s LAVA Therapeutics NV Holding Summary
As of 2025-03-31, Merck & Co., Inc. held 1.15 Mil shares of LAVA Therapeutics NV(LVTX), totaling $1.46 Mil. This investment constitutes 0.89% of their stock portfolio, and Merck & Co., Inc. now holds 4.37% of the outstanding LAVA Therapeutics NV(LVTX) stock.
The initial trade took place in 2024Q4. Based on historical transaction data and LVTX's current price of $1.36, Merck & Co., Inc.'s estimated gain on his LVTX holdings is $-241,362.45, reflecting a -13.38% gain to date.
Merck & Co., Inc. LVTX ($1.36) Holding Chart
Merck & Co., Inc. LVTX ($1.36) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers